Target Information
| Target General Infomation | |||||
|---|---|---|---|---|---|
| Target ID |
T47888
|
||||
| Former ID |
TTDI02522
|
||||
| Target Name |
Sphingosine-1-phosphate receptor-2
|
||||
| Gene Name |
S1PR2
|
||||
| Synonyms |
Endothelial differentiation G-protein coupled receptor 5; S1P receptor 2; S1P receptor Edg-5; S1P2; Sphingosine 1-phosphate receptor Edg-5; S1PR2
|
||||
| Target Type |
Research
|
||||
| Disease | Hypertension [ICD9: 401; ICD10: I10-I16] | ||||
| Function |
Receptor for the lysosphingolipid sphingosine 1- phosphate (S1P). S1P is a bioactive lysophospholipid that elicits diverse physiological effect on most types of cells and tissues. When expressed in rat HTC4 hepatoma cells, is capable of mediating S1P-induced cell proliferation and suppression of apoptosis.
|
||||
| BioChemical Class |
GPCR rhodopsin
|
||||
| UniProt ID | |||||
| Sequence |
MGSLYSEYLNPNKVQEHYNYTKETLETQETTSRQVASAFIVILCCAIVVENLLVLIAVAR
NSKFHSAMYLFLGNLAASDLLAGVAFVANTLLSGSVTLRLTPVQWFAREGSAFITLSASV FSLLAIAIERHVAIAKVKLYGSDKSCRMLLLIGASWLISLVLGGLPILGWNCLGHLEACS TVLPLYAKHYVLCVVTIFSIILLAIVALYVRIYCVVRSSHADMAAPQTLALLKTVTIVLG VFIVCWLPAFSILLLDYACPVHSCPILYKAHYFFAVSTLNSLLNPVIYTWRSRDLRREVL RPLQCWRPGVGVQGRRRGGTPGHHLLPLRSSSSLERGMHMPTSPTFLEGNTVV |
||||
| Pathways | |||||
| KEGG Pathway | Sphingolipid signaling pathway | ||||
| Neuroactive ligand-receptor interaction | |||||
| Pathway Interaction Database | S1P3 pathway | ||||
| Sphingosine 1-phosphate (S1P) pathway | |||||
| S1P2 pathway | |||||
| Reactome | G alpha (i) signalling events | ||||
| Lysosphingolipid and LPA receptors | |||||
| WikiPathways | Signal Transduction of S1P Receptor | ||||
| Small Ligand GPCRs | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| References | |||||
| Ref 526465 | Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist. Biochem Biophys Res Commun. 2002 Dec 6;299(3):483-7. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.